"The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Multiple myeloma is a form of blood cancer that p"...
Velcade Patient Information including How Should I Take
In this Article
- What is bortezomib (Velcade)?
- What are the possible side effects of bortezomib (Velcade)?
- What is the most important information I should know about bortezomib (Velcade)?
- What should I discuss with my healthcare provider before receiving bortezomib (Velcade)?
- How is bortezomib given (Velcade)?
- What happens if I miss a dose (Velcade)?
- What happens if I overdose (Velcade)?
- What should I avoid while receiving bortezomib (Velcade)?
- What other drugs will affect bortezomib (Velcade)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving bortezomib (Velcade)?
You should not use this medication if you are allergic to bortezomib, mannitol, or boron.
To make sure bortezomib is safe for you, tell your doctor if you have:
- liver disease;
- kidney disease, or if you are on dialysis;
- a bleeding or blood clotting disorder;
- a low level of platelets or white or red blood cells;
- heart disease, congestive heart failure;
- herpes or a history of shingles;
- high or low blood pressure; or
- nerve problems such as numbness, burning, pain, or tingly feeling.
FDA pregnancy category D. Do not use bortezomib if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.
It is not known whether bortezomib passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using bortezomib.
How is bortezomib given (Velcade)?
Bortezomib is injected into a vein through an IV.
You will receive this injection in a clinic or hospital setting. A doctor, nurse, or other healthcare provider will give you this injection.
Bortezomib is usually injected 2 times a week for 2 weeks, followed by 10 days without an injection. Bortezomib may also be given once a week for 4 weeks followed by 13 days without an injection. Follow your doctor's instructions about your individual dosing schedule.
Bortezomib can lower blood cells that help your body fight infections and help your blood to clot. Your blood will need to be tested often. Your cancer treatments may be delayed based on the results of these tests.
Additional Velcade Information
Velcade - User Reviews
Velcade User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Find out what women really need.